Ropeginterferon dose-escalation strategies in polycythemia vera: a systematic review and meta-analysis

Abstract Background Ropeginterferon alfa-2b is increasingly used as a long-acting interferon therapy for polycythemia vera (PV), providing hematologic and molecular benefits. However, clinical studies have implemented different dose-escalation strategies, and their impact on outcomes has not been sy...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Seug Yun Yoon, Suyeon Park, Sun Young Jeong, Min-Young Lee, Kyoung Ha Kim, Namsu Lee, Jong-Ho Won, Sung-Eun Lee
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2026-04-01
Schriftenreihe:	BMC Cancer
Schlagworte:	Ropeginterferon alfa-2b Polycythemia vera Dose-escalation Hematologic response Molecular response
Online-Zugang:	https://doi.org/10.1186/s12885-026-15939-x
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!